Tracking of Blood Pressure in Children and Adolescents in Germany in the Context of Risk Factors for Hypertension.
Blood pressure (BP) elevation is much more common among children and adolescents than previously thought. Moreover, BP in childhood correlates with BP in adulthood ; hence children with elevated BP have a higher probability of developing hypertension in adulthood than children with lower BP. However, the usefulness of universal pediatric BP screening is strongly debated due to the only moderate BP tracking correlation from childhood to adulthood [1-4].
BP tracking correlation has two aspects: the stability of BP ranking relative to others over a specified period of time (calculated as tracking coefficients) and the predictability of future values from baseline values. Meta-analyses have reported moderate tracking coefficients of 0.42-0.38 for SBP and 0.41-0.28 for DBP from childhood to adulthood [1, 3]. While several studies have investigated BP tracking in children and adolescents and have compared different age groups as well as BP tracking over different time periods, little is known on whether having risk factors for hypertension, such as overweight and obesity, low birthweight, or parental hypertension, is associated with higher BP tracking correlation from childhood to adolescence/young adulthood. Moreover, the predictability of BP measurements from hypertension risk factors in clinically meaningful terms such as positive and negative predictive values has been reported only in the context of screening, not of tracking .
Therefore, the aim of this study is twofold: (1) to investigate six year BP tracking correlation coefficients from childhood to adolescence/young adulthood in a large population-based sample with a broad baseline age range of 3 to 17 years and to illustrate whether this aspect of tracking is stronger in subgroups with additional hypertension risk factors; and (2) to analyse the predictability of future BP values above the hypertension threshold from previous BP and hypertension risk factors and to quantify this predictability using different measures of association including odds ratios (OR) and predictive values.
2.1. Study Population. The German Health Interview and Examination Survey for Children and Adolescents (KiGGS) is a nationwide study based on a stratified population-registry sample of 17,641 participants aged 0-17 years living in Germany (response rate 67%), including 14,835 participants aged 3-17 years . Details on the baseline and follow-up surveys including its several parallel study modules were published previously [6-8]. At baseline, about half of the participants were invited to take part in the "Motorik Modul Study" (MoMo; response rate 58%) . The six-year MoMo follow-up had a response rate of 48% . The present analysis includes data from 2686 children and adolescents who participated in the KiGGS baseline study KiGGSO ([t.sub.0] 2003-2006; participants aged 3 to 17 years) and the MoMo follow-up (h 2009-2012; participants aged 9 to 24 years) with complete BP data sets and who have not taken antihypertensive medication at [t.sub.0] (unfortunately we do not have information on medication use at [t.sub.1]). The proportion of complete data sets was higher for those 3-10 years old at [t.sub.0] than for those 11-17 years old. Analyses were stratified by age group: 3-10 years at [t.sub.0] and 9-17 years at [t.sub.1] vs. 11-17 years at [t.sub.0] and 18-24 years at [t.sub.1]. We therefore excluded 144 participants who did not fall into these two groups in order to have a clear cutoff in the age group analysis and not mix both hypertension definitions (percentile and mmHg based; see below), leaving 2542 participants (1269 males and 1273 females) for analysis. Additional follow-up data were available from the telephone interview KiGGS1 2009-2012 .
BP measurement methods were standardized and followed the same protocol in KiGGS0 2003-2006 ([t.sub.0]) and in the MoMo study 2009-2012 ([t.sub.1]). At both time-points, BP measurements were taken in the sitting position on a height-adjustable chair with a backrest, the right forearm resting on a table at the level of the heart, the elbow slightly bent, the legs uncrossed, and the feet placed firmly on the floor. Four cuff sizes (cuff bladder in cm 6 x 12, 9 x 18, 12 x 23, or 17 x 38.6) were available, which had to cover at least two-thirds of the upper arm length (from the axilla to the antecubital fossa). Two readings of systolic (SBP), diastolic blood pressure (DBP), mean arterial BP, and heart rate were obtained at a two-minute interval with an automated upper arm oscillometric device (Datascope Accutorr Plus, Mahwah, NJ) after a nonstrenuous part of the examination and an additional 5-minute rest in both surveys [9, 10]. The mean of the 2 systolic and diastolic measurements was used for this analysis.
BP in children is age, gender, and height dependent; therefore, it is not possible, as for adults, to designate a single BP threshold to define hypertension. BP reference percentiles  based on KiGGS data from nonoverweight children were used according to German guidelines : hypertensive BP measurement was SBP or DBP at or above the 95th age-, sex-, and height-specific percentile for children and adolescents under 18 years, or BP [greater than or equal to] 140/90 mmHg irrespective of the percentile. For young adults aged 18 years or older, the absolute cutoff for hypertension ([greater than or equal to]140/90 mmHg) was applied. Since percentile-based cutoffs in children and the 140/90 mmHg cutoff in adults are not equivalent, analyses were stratified accordingly: baseline ages 3 to 10 years with Thages 9 to 17 years vs. baseline ages 11 to 17 years with Thages 18 to 24 years.
In addition, weight and height were measured at [t.sub.0] and [t.sub.1] according to a common protocol. Weight was measured in underwear to the nearest 0.1 kg with a calibrated scale (Seca, Birmingham, United Kingdom) according to a standardized protocol . BMI was calculated as the ratio of weight (in kg) by [height.sup.2] (in [m.sup.2]) and rounded to 3 digits. BMI was categorized as underweight, normal weight, overweight, and obese according to the International Obesity Task Force (IOTF) cutoffs defined by the age-specific percentiles in <18-year olds, which at the age 18 and older correspond to the adult cutoff points for overweight 25 kg/[m.sup.2] and obesity 30 kg/[m.sup.2] . BMI trajectory was defined as the BMI course between [t.sub.0] and [t.sub.1] in 4 categories: "persistently low or normal" defined as under- or normal weight at [t.sub.0] and at [t.sub.1]; "resolution" as overweight or obese at [t.sub.0] and normal or underweight at Th "persistently overweight/obesity" (at [t.sub.0] and at [t.sub.1]); and "incident overweight/obesity" as under- or normal weight at [t.sub.0] and overweight or obese at [t.sub.1].
Information on physical activity was collected only in [t.sub.0]: in children aged 3 to 10 years it was assessed through parentreported frequency of sports activities per week (categories: 3 or more, 1-2, and less than once)  and in children aged 11 to 17 years through self-reported leisure time physical activities that makes them sweat or get out of breath (categories: [less than or equal to] 2.0, 2.1-4.9, and 5.0-31.0 hours per week) .
Birth weight (in g) was reported by the mother at [t.sub.0]; we have classified the variable into less than 2500 g, as low birth weight, or greater than 2500 g.
Parental hypertension was collected at [t.sub.1] with the question: has the mother or father of the study participant ever been diagnosed by a doctor as having hypertension or high blood pressure?
2.2. Statistical Analysis. The analysis was performed in two parts. First, BP tracking was estimated by calculating Spearman's rank-order correlation coefficients stratified by sex and age and potential hypertension risk factors (overweight/obesity, birthweight and parental hypertension). For this purpose, four age groups were chosen: 3 to 6, 7 to 10, 11 to 14, and 15 to 17 years. In the first two age groups, the rank order of [t.sub.0]-percentiles was correlated with the rank order of [t.sub.1]-percentiles. For the last two groups, the rank order of [t.sub.0]- percentiles were correlated with the rank order of [t.sub.1] mmHg values.
For testing statistical differences between correlation coefficients, we have used the software cocor (http://comparingcorrelations.org/) .
In the second part of the analysis, we determined the proportion of participants with hypertensive BP measurement at [t.sub.0] and [t.sub.1]. For calculating the positive predictive value (PPV) of hypertensive BP at [t.sub.0] for future hypertensive BP (six years later at [t.sub.1]), as well as the negative predictive value (NPV) of normotensive BP at [t.sub.0] for future normotensive BP, we used the software MedCalc (https://www.medcalc.org/ calc/diagnostic_test.php). We calculated the PPV and NPV also for risk factor combinations, e.g., for having hypertensive BP and being obese at [t.sub.0]. In sensitivity analyses, we checked whether the results were altered when using weighting factors in the analysis. These weights take selective participation in the MoMo study and the drop-out between [t.sub.0] and [t.sub.1] into account. They are the inverse of the probability to participate in the MoMo study/the follow-up, estimated in a logistic regression model including several relevant KiGGS variables as predictors. Since no weights are available for the exact population under study here, we used three existing sets of weights: longitudinal weights adjusting the KiGGS followup to the KiGGS baseline, longitudinal weights adjusting the MoMo follow-up to the MoMo baseline, and cross-sectional MoMo weights adjusting the MoMo follow-up to the KiGGS1 follow-up.
Furthermore, we investigated the prediction of hypertensive h-BP from [t.sub.0]-BP and other baseline and follow-up risk factors for hypertension, using logistic regression models. Models were run separately for the [t.sub.0]-age-group 3 to 10 years (percentile-defined [t.sub.1]-hypertension) and the [t.sub.0]-age-group 11 to 17 years (140/90 mmHg threshold [t.sub.1]-hypertension). STATA SE14.1 was used for the analyses.
The characteristics of the 2542 study participants (1269 males and 1273 females) at baseline (2003-2006) and six year follow-up (2009-2012) are presented in Table 1. At six-year follow-up, mean SBP had significantly increased by 14.8 mmHg in males and by 11.9 mmHg in females. In addition, the proportion of overweight in males and obesity in both sexes was at follow-up statistically significantly greater compared to baseline (Table 1).
Spearman rank-order correlations for BP tracking from childhood to adolescence/young adulthood are shown in Table 2. Tracking coefficients were higher for SBP (ranging for sex-age groups from 0.33 to 0.50) than for DBP (ranging for sex-age groups from 0.19 to 0.39). Although tracking coefficients increased with age in males, this increase was not statistically significant. Other differences between sex and age groups were as well not statistically significant.
The BP tracking coefficients stratified by birthweight, parental hypertension and BMI trajectories remained in the order of magnitude of the tracking coefficients for the overall sex-age groups; i.e., children with these hypertension risk factors did not have substantially higher SBP or DBP tracking correlation coefficients compared to children without these risk factors (data not shown).
We investigated the prevalence of hypertensive BP measurement at baseline and at follow-up in a younger age group (baseline age 3 to 10 years, pediatric percentile-based definition of hypertensive BP at [t.sub.1]) and an older age group (baseline age 11 to 17 years, adult definition of hypertensive BP at [t.sub.1]) (Figure 1). Among children aged 3 to 10 years, 7.9% (95% Ci 6.7-9.1) had hypertensive BP at baseline. Of these, 39% (n = 62 out of 159) also had hypertensive BP at follow-up. The proportion of children with persistent hypertensive BP (at [t.sub.0] and [t.sub.1]) accounted for 3.1% of this age group; incident hypertensive BP (children with normal BP at [t.sub.0] and hypertensive BP measurement at [t.sub.1]) was observed in 11.6%; resolution of hypertensive BP (children with hypertensive BP at [t.sub.0] and a normal BP at [t.sub.1]) was observed in 4.8% and the proportion of persistently normal BP in the 3- to 10-year-old group accounted for 80.5%. Among children and adolescents aged 11 to 17 years, 11.2% (95% CI 8.6-14) had hypertensive BP at baseline. Of these, 34% (n = 20 out of 59) also had hypertensive BP at follow-up. In this age group, persistent hypertensive BP accounted for 3.8%; incident hypertensive BP was observed in 12%; resolution of hypertensive BP in 7.4% and persistently normal BP in 77% of the study population (Figure 1).
The univariate and multivariable logistic regression (Table 3) showed the factors associated with having hypertensive BP at [t.sub.1]. In the models for both the younger and the older age group hypertensive BP at [t.sub.0] was one of the major determinants (OR 4.25 (95% CI 2.90-6.23) and OR 3.35 (95% CI 1.60-7.01)). Further, increasing age was also identified as a risk factor for hypertensive BP at follow-up in both age groups. In the 3- to 10-year-old group, children with a persistently overweight/obesity as well as those with an incident overweight/obesity were more likely to have hypertensive BP at % (OR 2.70 (95% CI 1.78-4.12) and OR 4.44 (95% CI 3.08-6.42), respectively) compared to children who had a persistently low or normal BMI. A gender difference was found only in the 11- to 17-year-old group, in which females were less likely to have hypertensive BP at [t.sub.1] compared with their male peers. Moreover, only in the 11- to 17-year-old group, parental hypertension was found to be a determinant for hypertensive BP at follow-up.
The probability of having hypertensive BP at six year follow-up increased with baseline BP percentile (Figure 2) but did not exceed 50% with the exception of a small subgroup (n = 8) of 11- to 17-year-old males having a SBP between 90th and 94.9th percentile (prehypertensive at [t.sub.0]) with a probability of 88% (95% CI 47-99.7) of having hypertensive BP at [t.sub.1].
The positive (PPV) and negative predictive values (NPV) according to age at baseline and risk factors are presented in Table 4. The PPV of baseline hypertensive BP for hypertensive BP six years later was 39% (95% CI 32-46) for 3- to 10-yearold children and 34% (95% CI 24-45) for 11- to 17-year olds. The NPV of non-hypertensive baseline BP was 87% (95% CI 87-88) and 87% (95% CI 85-88) respectively. In the 3to 10-year-old group, the PPV increased as risk factors were combined: for instance, 53% (95% CI 30-76) of 3- to 10-yearold children with a hypertensive BP and obesity at baseline also had hypertensive BP six years later. In the 11- to 17-yearold group, similar probabilities of having hypertensive BP at follow-up were observed in obese children at baseline (50%; 95% CI27-74) and children with a hypertensive BP at baseline and parental hypertension (48%; 95% CI 30-67) (Table 4).
This study investigates different aspects of BP tracking from childhood to adolescence/young adulthood with recent population-based data from Germany. Applying various metrics for assessing tracking including correlation coefficients, positive predictive values, and ORs from multivariable predictive modelling, BP tracking from childhood to adolescence and young adulthood was generally moderate. Our results confirm previous findings that BP in childhood and adolescence is one of the strongest predictors of future BP; however, it is one of the strongest predictors among several moderate or weak predictors. Among children and adolescents aged 3 to 17 years with hypertensive BP at baseline (mean of two measurements taken on one occasion), about one in three had hypertensive BP six years later. In population subgroups of children with additional hypertension risk factors such as overweight or parental hypertension, the PPV of baseline hypertensive BP increased but was not much higher than 50%.
In line with previous findings, we found moderate BP tracking coefficients, higher for SBP than for DBP [1-3]. Stratified by age and sex, we found a SBP tracking correlation in the range of 0.33 to 0.50 and for DBP in the range of 0.19 to 0.39, which was similar to the meta-analysis of Chen et al.  who found a mean correlation coefficient of 0.38 for SBP and of 0.28 for DBP.
One could ask whether BP tracking coefficients become larger among children with additional risk factors for hypertension, but in fact mathematically they are expected to remain similar or even become smaller, as verified with data from this study (results not shown). This happens since in subgroups with additional hypertension risk factors, BP values are more similar than in an unselected group and ranking to a greater extent due to chance. In other words, for combinations of risk factors, tracking coefficients are not an appropriate measure for assessing the predictability of future BP values.
Our results confirm previous findings that risk factors for hypertensive BP in young adulthood can be identified in childhood and adolescence [2,17]. However, the associations were moderate. After adjusting for various hypertension risk factors including overweight/obesity and parental hypertension, a child aged 3 to 10 years with hypertensive BP was more likely to have hypertensive BP six years later than a child in the same age group with a normal BP (OR 4.25, 95% CI 2.906.23). For the age group 11 to 17 years the respective adjusted OR was 3.35 (95% CI 1.60-7.01).
The association between overweight/obesity and hypertension in children was observed in several studies [18-20]. Our study showed that 36% of 3- to 10-year-old and 50% of 11- to 17 year-old obese children at baseline had a hypertensive BP at follow-up. The multivariable logistic regression analyses revealed that 3- to 10-year-old participants with a persistently or incidentally overweight/obesity were more likely to have a hypertensive BP at follow-up compared to participants with a persistently low or normal BMI trajectory, suggesting a potential action for prevention of future hypertension. In this regard, other studies have shown that children with higher BMI at follow-up changed BP standard deviation scores from initially normal to higher BP values . Moreover, it has been observed that changes in BMI during growth predicted BP levels during adolescence ; for instance, the study of Kelly et al.  showed that the resolution of elevated BP in the transition from childhood to adulthood could be partially explained by improvements in associated factors such as by decreasing the BMI z-score between childhood and adulthood.
Our univariable logistic regression analysis showed that children with hypertensive parents were at higher risk of hypertension at follow-up compared to children without hypertensive parents. However, this was only confirmed in the multivariable analysis of 11-17-year olds. Children and adolescents with parental hypertension had an 18% and 21% probability of having a hypertensive BP at follow-up (Table 4). A familial predisposition for hypertension was reported in previous studies [23, 24]; furthermore, it has been evaluated whether BP screening should target only children with a parental hypertension instead of all children (universal screening), with the conclusion that this may not be a substantially better strategy .
In our data, obesity of the child/adolescent at [t.sub.0] was a significantly stronger predictor for hypertension at [t.sub.1] than parental hypertension in both age groups (Table 4).
Consistent with the literature [25-27] we observed male sex as a riskfactor for hypertension in young adults: Figure 2 showed that 11- to 17-year-old males at baseline had a higher probability for having a hypertensive BP at follow-up (18 to 24 years) compared to females and Table 3 presented an OR = 0.33 (95% CI 0.18-0.61) for 11- to 17-year-old females at baseline, where they were less likely to have a hypertensive BP at follow-up compared to their male peers.
Contrary to other reports [28, 29], our study did not find a significant association between low birthweight and hypertension.
Even though we did not find significant associations between physical activity at [t.sub.0] and hypertensive BP at follow-up, our estimates showed the tendency of a negative correlation between these two variables, which is in line with other studies [30, 31].
Our study does not intend to estimate the prevalence of hypertension in children, as the diagnosis of hypertension requires, among other things, BP measurements on several occasions; however, the proportion of children and adolescents with persistently elevated BP in our study was 3.1% for 3- to 10-year olds at baseline and 3.8% for 11- to 17-year olds, which is in line with studies reporting prevalences of sustained hypertension in children and adolescents of 1% to 5% [32-34].
Major strengths of this study are the large national population database, coverage of a wide age range (3 to 17 years), the six-year follow-up, and standardized BP measurements according to the same protocol at baseline and follow-up examinations. However, despite using the same BP measurement devices, identical resting times, and the same measurement protocol, including performing BP measurements before motor performance testing, we cannot exclude the possibility that the environment and expectation of an extensive motor testing like in the MoMo study could have influenced BP at follow-up, leading to somewhat higher BP values and somewhat lower tracking indices. Another limitation is the possible selection bias arising from selective participation in the MoMo study and from longitudinal dropout. Sensitivity analyses with weights that partially account for this selection showed somewhat lower predictive values and thus did not alter the main conclusions. A further limitation is that the rule for KiGGS0 (2003-2006) was that the cuff should cover at least two-thirds of the upper arm length while current recommendations (2016 ESH guidelines ) suggest that the cuff size should cover 80-100% of the individual's arm circumference. Another limitation is that we had only two time points for assessment of the tracking; however, the KiGGS study just completed its second wave, allowing a future analysis of BP trajectories over a 10-year follow-up .
In conclusion, our analysis with recent population-based data from Germany shows that BP in children and adolescents tracks only moderately over six years; however, BP in childhood is the strongest independent predictor for future hypertensive BP measurements.
The data used to support the findings of this study are available from the corresponding author upon request.
Conflicts of Interest
The authors declare that they have no conflicts of interest.
The authors thank the participants of the KiGGS and MoMo studies and all their colleagues who conducted and contributed with these studies: partial presentation of the manuscript (abstract) for DGEpi Congress 2017 in Gesundheitswesen 2017; 79(08/09): 656-804 DOI: 10.1055/s-0037-1605847. The study has been financed by the Robert Koch Institute, DZHK and the Institute for Sports and Sport Science.
 X. Chen and Y. Wang, "Tracking of blood pressure from childhood to adulthood: A systematic review and meta-regression analysis," Circulation, vol. 117, no. 25, pp. 3171-3180, 2008.
 R. K. Kelly, R. Thomson, K. J. Smith, T. Dwyer, A. Venn, and C. G. Magnussen, "Factors Affecting Tracking of Blood Pressure from Childhood to Adulthood: The Childhood Determinants of Adult Health Study," Journal of Pediatrics, vol. 167, no. 6, pp. 1422-1428, 2015.
 A. M. Toschke, L. Kohl, U. Mansmann, and R. Von Kries, "Meta-analysis of blood pressure tracking from childhood to adulthood and implications for the design of intervention trials," Acta Paediatrica, vol. 99, no. 1, pp. 24-29, 2010.
 E. Lurbe, E. Agabiti-Rosei, J. K. Cruickshanket al., "2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents," Journal of Hypertension, vol. 34, no. 10, pp. 1887-1920, 2016.
 C. Bloetzer, F. Paccaud, M. Burnier, P Bovet, and A. Chiolero, "Performance of parental history for the targeted screening of hypertension in children," Journal of Hypertension, vol. 33, no. 6, pp. 1167-1173, 2015.
 B.-M. Kurth, P Kamtsiuris, H. Holling et al., "The challenge of comprehensively mapping children's health in a nation-wide health survey: Design of the German KiGGS-Study," BMC Public Health, vol. 8, 2008.
 M. O. Wagner, K. Bos, D. Jekauc et al., "Cohort Profile: The Motorik-Modul Longitudinal Study: Physical fitness and physical activity as determinants of health development in German children and adolescents," International Journal of Epidemiology, vol. 43, no. 5, pp. 1410-1416, 2014.
 M. Lange, H. G. Butschalowsky, F. Jentsch et al., "The first KiGGS follow-up (KiGGS Wave 1): Study conduct, sample design, and response," Bundesgesundheitsblatt--Gesundheitsforschung --Gesundheitsschutz, vol. 57, no. 7, pp. 747-761, 2014.
 H. Neuhauser and M. Thamm, "Blood pressure measurement in the German Health Interview and Examination Survey for Children and Adolescents (KiGGS): Methodology and initial results," Bundesgesundheitsblatt--Gesundheitsforschung--Gesundheitsschutz, vol. 50, no. 5-6, pp. 728-735, 2007.
 A. Worth, A. Woll, C. Albrecht et al., MoMo-Langsschnittstudie "Physical Fitness and Physical Activity as Determinants of Health Development in Children and Adolescents, Karlsruhe Germany: Karlsruher Institut fur Technologie (KIT), 2015.
 H. K. Neuhauser, M. Thamm, U. Ellert, H. W. Hense, and A. S. Rosario, "Blood pressure percentiles by age and height from nonoverweight children and adolescents in Germany," Pediatrics, vol. 127, no. 4, pp. e978-e988, 2011.
 A. Hager, E. Wuohl, G. Boonner, M. Hulpke-Wette, S. Laoer, and J. Weil, S2k Leitlinie Padiatrische Kardiologie, Padiatrische Nephrologie und Padiatrie: Arterielle Hypertonie: Deutsche Gesellschaft fur Padiatrische Kardiologie, 2015.
 T. J. Cole and T. Lobstein, "Extended international (IOTF) body mass index cut-offs for thinness, overweight and obesity," Pediatric Obesity, vol. 7, no. 4, pp. 284-294, 2012.
 K. Manz, S. Krug, A. Schienkiewitz, and J. D. Finger, "Determinants of organised sports participation patterns during the transition from childhood to adolescence in Germany: Results of a nationwide cohort study," BMC Public Health, vol. 16, no. 1, 2016.
 J. D. Finger, G. B. M. Mensink, W. Banzer, T. Lampert, and T. Tylleskaor, "Physical activity, aerobic fitness and parental socioeconomic position among adolescents: The German Health Interview and Examination Survey for Children and Adolescents 2003-2006 (KiGGS)," International Journal of Behavioral Nutrition and Physical Activity, vol. 11, no. 1, article no. 43, 2014.
 B. Diedenhofen and J. Musch, "Cocor: A comprehensive solution for the statistical comparison of correlations," PLoS ONE, vol. 10, no. 4, 2015.
 R. M. Lauer and W. R. Clarke, "Childhood risk factors for high adult blood pressure: The Muscatine study," Pediatrics, vol. 84, no. 4, pp. 633-641, 1989.
 R. Din-Dzietham, Y. Liu, M.-V. Bielo, and F. Shamsa, "High blood pressure trends in children and adolescents in national surveys, 1963 to 2002," Circulation, vol. 116, no. 13, pp. 1488-1496, 2007.
 B. Falkner, S. S. Gidding, G. Ramirez-Garnica, S. A. Wiltrout, D. West, and E. B. Rappaport, "The relationship of body mass index and blood pressure in primary care pediatric patients," Journal of Pediatrics, vol. 148, no. 2, pp. 195-200, 2006.
 R.-C. Huang, S. Burrows, T. A. Mori, W. H. Oddy, and L. J. Beilin, "Lifecourse adiposity and blood pressure between birth and 17 years old," American Journal of Hypertension, vol. 28, no. 8, pp. 1056-1063, 2015.
 A. Miersch, M. Vogel, R. Gausche et al., "Blood pressure tracking in children and adolescents," Pediatric Nephrology, vol. 28, no. 12, pp. 2351-2359, 2013.
 A. Kollias, K. Pantsiotou, N. Karpettas, L. Roussias, and G. S. Stergiou, "Tracking of blood pressure from childhood to adolescence in a Greek cohort," European Journal of Public Health, vol. 22, no. 3, pp. 389-393, 2012.
 T. J. Niiranen, E. L. McCabe, M. G. Larson et al., "Risk for hypertension crosses generations in the community: Amulti-generational cohort study," European Heart Journal, vol. 38, no. 29, pp. 2300-2308, 2017.
 R. F. Theodore, J. Broadbent, D. Nagin et al., "Childhood to Early-Midlife Systolic Blood Pressure Trajectories: Early-Life Predictors, Effect Modifiers, and Adult Cardiovascular Outcomes," Hypertension, vol. 66, no. 6, pp. 1108-1115, 2015.
 H. K. Neuhauser, C. Adler, A. S. Rosario, C. Diederichs, and U. Ellert, "Hypertension prevalence, awareness, treatment and control in Germany 1998 and 2008-11," Journal of Human Hypertension, vol. 29, no. 4, pp. 247-253, 2015.
 G. Sarganas and H. K. Neuhauser, "The persisting gender gap in hypertension management and control in Germany: 1998 and 2008-2011," Hypertension Research, vol. 39, no. 6, pp. 457-466, 2016.
 K. Wolf-Maier, R. S. Cooper, J. R. Banegas et al., "Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States," The Journal of the American Medical Association, vol. 289, no. 18, pp. 2363-2369, 2003.
 M. Gamborg, L. Byberg, F. Rasmussen et al., "Birth weight and systolic blood pressure in adolescence and adulthood: Meta-regression analysis of sex- and age-specific results from 20 nordic studies," American Journal of Epidemiology, vol. 166, no. 6, pp. 634-645, 2007.
 M. Mu, S.-F. Wang, J. Sheng et al., "Birth weight and subsequent blood pressure: A meta-analysis," Archives of Cardiovascular Diseases, vol. 105, no. 2, pp. 99-113, 2012.
 L. B. Andersen, "Tracking of risk factors for coronary heart disease from adolescence to young adulthood with special emphasis on physical activity and fitness. A longitudinal study," Danish Medical Journal, vol. 43, no. 5, pp. 407-418, 1996.
 D. A. Jenner, R. Vandongen, and L. J. Beilin, "Relationships between blood pressure and measures of dietary energy intake, physical fitness, and physical activity in Australian children aged 11-12 years," Journal of Epidemiology and Community Health, vol. 46, no. 2, pp. 108-113, 1992.
 B. Falkner, "Hypertension in children and adolescents: epidemiology and natural history," Pediatric Nephrology, vol. 25, no. 7, pp. 1219-1224, 2010.
 A. R. Marras, P. P. Bassareo, and M. Ruscazio, "The prevalence of paediatric hypertension, emphasising the need to use specific population references: The Sardinian Hypertensive Adolescents Research Programme Study," Cardiology in the Young, vol. 19, no. 3, pp. 233-238, 2009.
 P. P. Bassareo and G. Mercuro, "Pediatric hypertension: An update on a burning problem," World Journal of Cardiology, vol. 6, no. 5, p. 253, 2014.
 E. Mauz, A. Gofiwald, P. Kamtsiuris et al. et al., "New data for action. Data collection for KiGGS Wave 2 has been completed," Journal of Health Monitoring, vol. 2, pp. 2-27, 2017.
Giselle Sarganas [ID], (1,2) Angelika Schaffrath Rosario, (1) Claudia Niessner, (3) Alexander Woll, (3) and Hannelore K. Neuhauser (1,2)
(1) Robert Koch Institute, Department of Epidemiology and Health Monitoring, Berlin, Germany
(2) DZHK (German Center for Cardiovascular Research), Partner Site Berlin, Germany
(3) Institute for Sports and Sport Science, Karlsruhe Institute of Technology, Karlsruhe, Germany
Correspondence should be addressed to Giselle Sarganas; sarganas- firstname.lastname@example.org
Received 1 August 2018; Accepted 10 September 2018; Published 26 September 2018
Academic Editor: Tomohiro Katsuya
Caption: Figure 1: Blood pressure in 2542 studyparticipants at baseline (2003- 2006) and at follow-up (2009-2012).
Caption: Figure 2: Probability of having hypertensive BP at six year follow-up (t1) according to baseline BP percentiles.
Table 1: Characteristics of the 2542 study participants (1269 males and 1273 females) at baseline (2003-2006) and at follow-up (2009-2012). Males Characteristics Baseline Follow-up p-value Age range (years) ([t.sub.0]) ([t.sub.1]) (3-17) (9-24) Mean age * 8.5 14.7 0.000 (8.3-8.7) (14.5-14.9) SBP (mmHg) * 102.8 117.6 0.000 (102.2-103.4) (116.8-118.5) DBP (mmHg) * 62.1 66.2 0.001 (61.7-62.5) (65.7-66.7) Hypertensive BP & 8.5% 15.7% 0.001 (71-10.2) (13.8-17.8) BMI (kg/[m.sup.2]) * 17.1 20.7 0.000 (16.9-17.2) (20.4-20.9) Underweight 9.8% 6.1% 0.001 (8.3-11.6) (4.9-7.5) Normal-weight 78.9% 72.5% 0.000 (76.6-81.1) (70.0-74.9) Overweight 9.1% 16.3% 0.000 (76-10.8) (14.4-18.5) Obese 2.2% 5.1% 0.000 (1.5-3.2) (4.0-6.5) Sports activities (3 or more 43.2% -- -- times/week) (3-10 years) (40.1-46.4) Sports activities (h/week) * 7.6 -- -- (11-17 years) (6.5-8.8) Parental hypertension -- 28.1% -- (25.7-30.8) Low birthweight 5.0% -- -- (<2500 g) (3.9-6.4) Females Characteristics Baseline Follow-up p-value Age range (years) ([t.sub.0]) ([t.sub.1]) (3-17) (9-24) Mean age * 8.5 14.8 0.000 (8.3-8.7) (14.6-15.0) SBP (mmHg) * 102.8 114.7 0.000 (102.3-103.4) (114.0-115.4) DBP (mmHg) * 62.7 66.0 0.001 (62.3-63.1) (65.5-66.5) Hypertensive BP & 8.6% 14.0% 0.000 (72-10.3) (12.2-16.0) BMI (kg/[m.sup.2]) * 17.1 20.5 0.000 (17.0-17.3) (20.3-20.8) Underweight 11.3% 9.4% 0.104 (9.7-13.2) (7.9-11.1) Normal-weight 74.0% 72.6% 0.372 (71.6-76.4) (70.0-75.0) Overweight 12.2% 13.8% 0.238 (10.5-14.1) (12.0-15.8) Obese 2.4% 4.3% 0.011 (1.7-3.4) (3.3-5.5) Sports activities (3 or more 35.5% -- -- times/week) (3-10 years) (32.4-38.6) Sports activities (h/week) * 5.2 -- -- (11-17 years) (4.7-5.7) Parental hypertension -- 30.3% -- (27.7-32.9) Low birthweight 6.3% -- -- (<2500 g) (5.1-78) * mean (95% CI). & SBP or DBP at or above the 95th age-, sex-, and height-specific percentile for children and adolescents under 18 years, or BP [greater than or equal to] 140/90 mmHg irrespective of the percentile. For young adults aged 18 years or older, the absolute cutoffs for hypertension ([greater than or equal to] 140/90 mmHg) were applied. Table 2: Spearman rank-order correlation coefficients for six year-tracking of BP in children and adolescents in Germany. Tracking coefficients Baseline age n SBP DBP 3-6 years (1) All 1063 0.38 0.24 Male 530 0.33 0.19 Female 533 0.44 0.30 7-10 years (1) All 953 0.42 0.36 Male 481 0.41 0.30 Female 472 0.42 0.42 11-14 years (2) All 320 0.34 0.34 Male 155 0.43 0.32 Female 165 0.36 0.38 15-17 years (2) All 206 0.47 0.36 Male 103 0.50 0.34 Female 103 0.46 0.39 (1) [t.sub.0]-BP and [t.sub.1]-BP in age-, sex-, and height-specific percentiles; (2) [t.sub.0]-BP in percentiles and [t.sub.1]-BP in mmHg. All Spearman rank-orderjsup/?correlation coefficients were statistically significant at a p-value <0.001. Table 3: Predictors of hypertensive BP * at six-year follow-up in children and adolescents in Germany. univariable analysis 3- to 10-year-olds OR (95% Cl) p-value (at baseline) Sex Male Ref 0.50 Female 1.09 (0.85-1.39) Age 1.14 (1.08-1.21) <0.001 BP [t.sub.0] normal (<P95) Ref <0.001 hypertensive ([greater than 4.44 (3.14-6.28) or equal to] P95) BMI trajectory ([t.sub.0] to [t.sub.1]) persistently low or normal Ref <0.001 resolution 1.74 (0.96-3.16) persistently overweight/obesity 3.87 (2.67-5.61) incident overweight/obesity 3.95 (2.83-5.51) Sport activities (times/week) <1 Ref 0.14 1-2 1.21 (0.85-1.73) [greater than or equal to] 3 1.42 (0.99-2.02) Parental hypertension No Ref 0.02 Yes 1.38 (1.06-1.80) Low birthweight (<2500g) No Ref 0.59 Yes 1.14 (0.70-1.88) 11- to 17-year-olds (at baseline) Sex Male Ref <0.001 Female 0.37 (0.22-0.61) Age 1.22 (1.07-1.40) <0.01 BP [t.sub.0] normal (<P95) Ref <0.001 hypertensive ([greater than 3.41 (1.87-6.23) or equal to] P95) BMI trajectory ([t.sub.0] to [t.sub.1]) persistently low or normal Ref 0.07 resolution 1.82 (0.58-5.70) persistently overweight/obesity 2.23 (1.19-4.16) incident overweight/obesity 1.50 (0.73-3.08) Physical activities (hours/week) [less than or equal to] 2.0 Ref 0.24 2.1-4.9 1.76 (0.76-4.07) 5.0-31.0 1.93 (0.90-4.13) Parental hypertension No Ref 0.03 Yes 1.78 (1.07-2.95) Low birthweight (<2500g) No Ref 0.46 Yes 0.57 (0.13-2.50) multivariable analysis 3- to 10-year-olds OR (95% Cl) p-value (at baseline) Sex Male Ref 0.19 Female 1.21 (0.91-1.59) Age 1.15 (1.08-1.23) <0.001 BP [t.sub.0] normal (<P95) Ref <0.001 hypertensive ([greater than 4.25 (2.90-6.23) or equal to] P95) BMI trajectory ([t.sub.0] to [t.sub.1]) persistently low or normal Ref <0.001 resolution 1.64 (0.86-3.11) persistently overweight/obesity 2.70 (1.78-4.12) incident overweight/obesity 4.44 (3.08-6.42) Sport activities (times/week) <1 Ref 0.07 1-2 1.30 (0.87-1.92) [greater than or equal to] 3 1.58 (1.06-2.35) Parental hypertension No Ref 0.48 Yes 1.11 (0.83-1.49) Low birthweight (<2500g) No Ref 0.69 Yes 1.12 (0.64-1.96) 11- to 17-year-olds (at baseline) Sex Male Ref <0.001 Female 0.33 (0.18-0.61) Age 1.21 (1.03-1.42) 0.02 BP [t.sub.0] normal (<P95) Ref 0.001 hypertensive ([greater than 3.35 (1.60-7.01) or equal to] P95) BMI trajectory ([t.sub.0] to [t.sub.1]) persistently low or normal Ref 0.32 resolution 0.85 (0.17-4.19) persistently overweight/obesity 1.96 (0.89-4.29) incident overweight/obesity 1.59 (0.65-3.88) Physical activities (hours/week) [less than or equal to] 2.0 Ref 0.42 2.1-4.9 1.75 (0.69-4.40) 5.0-31.0 1.70 (0.74-3.91) Parental hypertension No Ref 0.04 Yes 1.85 (1.02-3.33) Low birthweight (<2500g) No Ref 0.56 Yes 0.62 (0.12-3.16) * Hypertensive BP: SBP or DBP at or above the 95th age-, sex-, and height-specific percentile for children and adolescents under 18 years or BP >140/90 mmHg irrespective of the percentile; for adults aged 18 or older: >140/90 mmHg. OR = odds ratio BP = blood pressure. Table 4: Positive (PPV) and negative predictive value (NPV) of various hypertension risk factors or risk factor combinations for hypertensive BP* at six-year follow-up. n Proportion at PPV % [t.sub.0] % (95% CI) Baseline age 3 to 10 years (95% CI) Hypertensive BP at [t.sub.0] 2016 7.9 (6.8-9.1) 39 (32-46) Overweight or obesity at [t.sub.0] 2011 12 (11-14) 27 (22-32) Obesity at [t.sub.0] 2011 2.2 (1.7-3.0) 36 (23-50) Parental hypertension 1942 29 (27-31) 18 (15-20) Hypertensive BP and overweight or 2011 2.0 (1.5-2.7) 48 (33-62) obesity at [t.sub.0] Hypertensive BP and obesity at 2011 0.7 (0.4-1.2) 53 (30-76) [t.sub.0] Hypertensive BP at [t.sub.0] and 1942 2.6 (2.0-3.4) 51 (38-64) parental hypertension Baseline age 11 to 17 years Hypertensive BP at [t.sub.0] 526 11 (8.8-14) 34 (24-45) Overweight or obesity at [t.sub.0] 525 17 (14-20) 24 (17-33) Obesity at [t.sub.0] 525 2.7 (1.6-4.5) 50 (27-74) Parental hypertension 481 32 (28-36) 21 (16-26) Hypertensive BP and overweight or 525 3.2 (2.0-5.1) 35 (17-59) obesity at [t.sub.0] Hypertensive BP and obesity at 525 0.6 (0.2-1.8) [section] [t.sub.0] Hypertensive BP at [t.sub.0] and 481 4.8 (3.2-71) 48 (30-67) parental hypertension n NPV % (95% CI) Baseline age 3 to 10 years Hypertensive BP at [t.sub.0] 2016 87 (87-88) Overweight or obesity at [t.sub.0] 2011 87 (86-88) Obesity at [t.sub.0] 2011 86 (85-86) Parental hypertension 1942 87 (86-88) Hypertensive BP and overweight or 2011 86 (86-86) obesity at [t.sub.0] Hypertensive BP and obesity at 2011 86 (85-86) [t.sub.0] Hypertensive BP at [t.sub.0] and 1942 86 (86-87) parental hypertension Baseline age 11 to 17 years Hypertensive BP at [t.sub.0] 526 87 (85-88) Overweight or obesity at [t.sub.0] 525 87 (85-88) Obesity at [t.sub.0] 525 86 (85-87) Parental hypertension 481 87 (85-89) Hypertensive BP and overweight or 525 85 (85-86) obesity at [t.sub.0] Hypertensive BP and obesity at 525 85 (85-85) [t.sub.0] Hypertensive BP at [t.sub.0] and 481 86 (85-87) parental hypertension ([section]) n < =10 subjects * Hypertensive BP: SBP or DBP at or above the 95th age-, sex-, and height-specific percentile for children and adolescents under 18 years or BP [greater than or equal to] 140/90 mmHg irrespective of the percentile; for adults aged 18 or older: [greater than or equal to]140/90 mmHg.
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||Research Article|
|Author:||Sarganas, Giselle; Rosario, Angelika Schaffrath; Niessner, Claudia; Woll, Alexander; Neuhauser, Hann|
|Publication:||International Journal of Hypertension|
|Date:||Jan 1, 2018|
|Previous Article:||Renal Dysfunction among Ghanaians Living with Clinically Diagnosed Hypertension in the Asutifi-South District: A Cross-Sectional Descriptive Study at...|
|Next Article:||Doctors' Knowledge of Hypertension Guidelines Recommendations Reflected in Their Practice.|